Incyte Announces Discontinuation Of Pancreatic Cancer Trial By: TalkMarkets February 11, 2016 at 18:07 PM EST Incyte announces discontinuation of Pancreatic Cancer trial. The stock drop by more than 9% today. Read More >> Related Stocks: Incyte Corp